173 related articles for article (PubMed ID: 8491233)
1. Study of the efficacy of nicorandil in patients with ischaemic heart disease using Exercise-T1-201 myocardial tomography.
Yamazaki J; Ohsawa H; Uchi T; Iida M; Nakano H; Hosoi H; Morishita T; Yabe Y; Koyama N; Komatsu H
Eur J Clin Pharmacol; 1993; 44(3):211-7. PubMed ID: 8491233
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT.
Yamazaki J; Iida M; Igarashi M; Hosoi H; Ishiguro S; Hou M; Morishita T; Nakano H; Yabe Y; Koyama N
Int J Clin Pharmacol Ther; 1994 Apr; 32(4):183-91. PubMed ID: 8032578
[TBL] [Abstract][Full Text] [Related]
3. [Effects of nicorandil on coronary collateral circulation depend on the donor arteries].
Umezawa S; Ogawara S; Okamoto Y; Igawa M; Aonuma K; Inada M; Korenaga M; Hiroe M; Marumo F
J Cardiol; 1996 Nov; 28(5):257-66. PubMed ID: 8953399
[TBL] [Abstract][Full Text] [Related]
4. Effect of nicorandil on abnormal coronary flow reserve assessed by exercise 201Tl scintigraphy in patients with angina pectoris and nearly normal coronary arteriograms.
Yamabe H; Namura H; Yano T; Fujita H; Kim S; Iwahashi M; Maeda K; Yokoyama M
Cardiovasc Drugs Ther; 1995 Dec; 9(6):755-61. PubMed ID: 8850379
[TBL] [Abstract][Full Text] [Related]
5. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina.
Chen JW; Lee WL; Hsu NW; Lin SJ; Ting CT; Wang SP; Chang MS
Am J Cardiol; 1997 Jul; 80(1):32-8. PubMed ID: 9205016
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of percutaneous transluminal coronary angioplasty in silent myocardial ischemia].
Hou M
J Cardiol; 1996 Apr; 27(4):179-86. PubMed ID: 8642504
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new vasodilator, nicorandil, on exercise-induced impairment of left ventricular function in patients with old myocardial infarction.
Yokota M; Horisawa T; Iwase M; Miyahara T; Yoshida J; Kamihara S; Noda S; Tsunekawa A; Koide M; Tsuzuki M
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S116-22. PubMed ID: 2447418
[TBL] [Abstract][Full Text] [Related]
8. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
Markham A; Plosker GL; Goa KL
Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
Guermonprez JL; Blin P; Peterlongo F
Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
Raftery EB; Lahiri A; Hughes LO; Rose EL
Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of efficacy of PTCA in patients with angina pectoris by exercise Tl-201 myocardial SPECT].
Uchi T
Kaku Igaku; 1991 Jun; 28(6):635-46. PubMed ID: 1895560
[TBL] [Abstract][Full Text] [Related]
12. Coronary dilating effects of intracoronary nicorandil. Comparison with isosorbide dinitrate.
Ejima J; Kaneda K; Moriyama H; Ohmura I; Maruyama T; Kaji Y; Tsuda Y; Kanaya S; Fujino T; Niho Y
Jpn Heart J; 1995 Nov; 36(6):699-707. PubMed ID: 8627976
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of relative washout rate (rW-R) in stress T1-201 myocardial SPECT].
Okuzumi I
Kaku Igaku; 1989 Mar; 26(3):329-38. PubMed ID: 2526266
[TBL] [Abstract][Full Text] [Related]
14. Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.
Suryapranata H
Eur Heart J; 1993 Jul; 14 Suppl B():16-21. PubMed ID: 8370366
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
[TBL] [Abstract][Full Text] [Related]
16. Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia.
Vegh A; Györgyi K; Papp JG; Sakai K; Parratt JR
Eur J Pharmacol; 1996 Jun; 305(1-3):163-8. PubMed ID: 8813547
[TBL] [Abstract][Full Text] [Related]
17. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
Aizawa T; Ogasawara K; Kato K
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419
[TBL] [Abstract][Full Text] [Related]
18. Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction.
Sakata Y; Kodama K; Komamura K; Lim YJ; Ishikura F; Hirayama A; Kitakaze M; Masuyama T; Hori M
Am Heart J; 1997 Jun; 133(6):616-21. PubMed ID: 9200388
[TBL] [Abstract][Full Text] [Related]
19. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
Why HJ; Richardson PJ
Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369
[TBL] [Abstract][Full Text] [Related]
20. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris.
Camm AJ; Maltz MB
Am J Cardiol; 1989 Jun; 63(21):61J-65J. PubMed ID: 2525328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
